Impairment of Left Ventricular Longitudinal Contraction is Associated with Serum Brain Natriuretic Peptide Concentration in Patients with Acute-Phase Kawasaki Disease

详细信息    查看全文

• 作者：Ikuo Hashimoto ; Kazuhiro Watanabe ; Mako Okabe ; Hisashi Kaneda
• 关键词：Kawasaki disease ; Left ventricular function ; Brain natriuretic peptide
• 刊名：Pediatric Cardiology
• 出版年：2015
• 出版时间：June 2015
• 年：2015
• 卷：36
• 期：5
• 页码：979-986
• 全文大小：801 KB
• 参考文献：1.Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K, Kawasaki Disease Research C (2005) Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 47:232-34View Article PubMed
  2.Bang S, Yu JJ, Han MK, Ko HK, Chun S, Choi HS, Kim YH, Ko JK, Park IS (2011) Log-transformed plasma level of brain natriuretic peptide during the acute phase of Kawasaki disease is quantitatively associated with myocardial dysfunction. Korean J Pediatr 54:340-44View Article PubMed Central PubMed
  3.Bergenzaun L, Ohlin H, Gudmundsson P, Willenheimer R, Chew MS (2013) Mitral annular plane systolic excursion (MAPSE) in shock: a valuable echocardiographic parameter in intensive care patients. Cardiovasc Ultrasound 11:16View Article PubMed Central PubMed
  4.Burns JC, Glodé MP (2004) Kawasaki syndrome. Lancet 364:533-44View Article PubMed
  5.Cho SY, Kim Y, Cha SH, Suh JT, Han MY, Lee HJ (2011) Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP? Ann Clin Lab Sci 41:360-63PubMed
  6.Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, Spiegelblatt L, Bonny Y, Vartian M, Montigny M (2009) Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 30:810-17View Article PubMed
  7.Harada K (1991) Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33:805-10View Article PubMed
  8.Harada M, Yokouchi Y, Oharaseki T, Matsui K, Tobayama H, Tanaka N, Akimoto K, Takahashi K, Kishiro M, Shimizu T (2012) Histopathological characteristics of myocarditis in acute-phase Kawasaki disease. Histopathology 61:1156-167View Article PubMed
  9.Hashimoto I, Watanabe K (2014) Alternation of right ventricular contraction pattern in healthy children. Circ J 78:1967-973View Article PubMed
  10.Hu K, Liu D, Herrmann S, Niemann M, Gaudron PD, Voelker W, Ertl G, Bijnens B, Weidemann F (2013) Clinical implication of mitral annular plane systolic excursion for patients with cardiovascular disease. Eur Heart J Cardiovasc Imaging 14:205-12View Article PubMed
  11.Iwashima S, Ishikawa T (2013) B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease. World J Pediatr 9:239-44
  12.Kaneko K, Yoshimura K, Ohashi A, Kimata T, Shimo T, Tsuji S (2011) Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide. Pediatr Cardiol 32:1106-109View Article PubMed
  13.Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M (2000) Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 42:241-48View Article PubMed
  14.Kishimoto S, Suda K, Teramachi Y, Nishino H, Kudo Y, Ishii H, Iemura M, Takahashi T, Okamura H, Matsuishi T (2011) Increased plasma type B natriuretic peptide in the acute phase of Kawasaki disease. Pediatr Int 53:736-41View Article PubMed
  15.Kitabatake A, Inoue M, Asao M, Ito H, Masuyama T, Tanouchi J, Morita T, Hori M, Yoshima H, Ohnishi K, Abe H (1984) Noninvasive evaluation of the ratio of pulmonary to systemic flow in atrial septal defect by duplex Doppler echocardiography. Circulation 69:73-9View Article PubMed
  16.Koestenberger M, Nagel B, Ravekes W, Avian A, Heinzl B, Fritsch P, Fandl A, Rehak T, Gamillscheg A (2012) Left ventricular long-axis function: reference values of the mitral annular plane systolic excursion in 558 healthy children and calculation of z-score values. Am Heart J 164:125-31View Article PubMed
  17.Koteda Y, Suda K, Kishimoto S, Ito S, Kudo Y, Nishino H, Ishii H, Iemura M, Matuishi T (2009) Impact of intravenous immunoglobulin infusion on longitudinal left ventricular performance in patients with acute Kawasaki disease of usual course. J Cardiol 54:45-1View Article PubMed
  18.Kurotobi S, Kawakami N, Shimizu K, Aoki H, Nasuno S, Takahashi K, Kogaki S, Ozono K (2005) Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 26:425-30View Article PubMed
  19.Lisi M, Ballo P, Cameli M, Gandolfo F, Galderisi M, Chiavarelli M, Henein MY, Mondillo S (2012) Mitral annular longitudinal function preservation after mitral valve repair: the MARTE study. Int J Cardiol 157:212-15View Article PubMed
  20.Matos J, Kronzon I, Panagopoulos G, Perk G (2012) Mitral annular plane systolic excursion as a surrogate for left ventricular ejection fraction. J Am Soc Echocardiogr: Off Publ Am Soc Echocardiogr 25:969-74View Article
  21.Matsubara T (1991) Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki disease. Arerugi (Allergy) 40:147-54
  22.McCandless RT, Minich LL, Wilkinson SE, McFadden ML, Tani LY, Menon SC (2013) Myocardial strain and strain rate in Kawasaki disease. Eur Heart J Cardiovasc Imaging 14:1061-068View Article PubMed
  23.McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M
• 作者单位：Ikuo Hashimoto (1)
  Kazuhiro Watanabe (1)
  Mako Okabe (1)
  Hisashi Kaneda (1)
  
  1. Department of Pediatrics, Toyama City Hospital, 2-1 Hokubu Machi, Imaizumi, Toyama City, Toyama, Japan
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  Cardiac Surgery
  Vascular Surgery
  
• 出版者：Springer New York
• ISSN：1432-1971

文摘

It is well known that brain natriuretic peptide (BNP) is elevated in the acute phase of Kawasaki disease (KD). We hypothesized that mitral annular plane systolic excursion (MAPSE) could identify LV dysfunction in the acute phase of KD. Fifty patients with KD were enrolled in this study. BNP sampling and an echocardiographic study were performed just before and after intravenous immunoglobulin administration. MAPSE was measured in M-mode in the apical four-chamber view. The %MAPSE was calculated as the MAPSE measured in the acute phase divided by that measured in the convalescent phase. We compared the acute and the convalescent phases of KD. The values of the MAPSE were significantly reduced (45 out of 50 patients) during the acute phase and immediately recovered in the convalescent phase (10.0?±?1.9 vs. 12.7?±?1.9?mm, P?<?0.0001). Of the parameters tested, %MAPSE was the only echocardiographic parameter that was associated with Log-BNP. Additionally, %MAPSE had a significant negative correlation with Log-BNP (r?=??.45, P?<?0.0039). Longitudinal LV contraction is impaired in the acute phase of KD, but it immediately recovers in the convalescent phase. Measuring the longitudinal LV contractility should be essential for evaluating LV function in the acute phase of KD, and MAPSE is useful for this evaluation.